PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1443379
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1443379
Antibiotic Susceptibility Testing Market size was valued at USD 4,100.32 Million in 2023, expanding at a CAGR of 6.1% from 2024 to 2032.
Antibiotic susceptibility testing involves assessing the effectiveness of antibiotics against bacterial pathogens to determine the most appropriate and efficacious treatment. This crucial diagnostic process aids healthcare professionals in selecting the most suitable antibiotic for patients, ensuring targeted and efficient therapeutic interventions. The testing is essential for managing infectious diseases, guiding antibiotic prescriptions, and combating the rise of antibiotic resistance by promoting judicious antibiotic use.
Antibiotic Susceptibility Testing Market- Market Dynamics
Increasing awareness about sustainable growth to propel market demand
The growth of the market is driven by an increase in cases of various infectious diseases, the rising adoption of personalized medicine, favorable initiatives by government bodies to combat infectious diseases, and the high prevalence of antimicrobial resistance. The surge in targeted diseases like pneumonia and bloodstream infections caused by E.coli, K. pneumonia, P. aeruginosa, and others is leading to a higher adoption of antimicrobial susceptibility tests (AST). Additionally, the growing research and development activities aimed at developing novel and effective therapeutic options for infectious diseases are boosting the utilization of AST in drug development. The increasing prevalence of personalized medicine and concerns about antibiotic overuse and misuse, which contribute to antimicrobial resistance (AMR), are expected to drive the adoption of AST for treating infectious diseases. Moreover, biotechnological, pharmaceutical, and biopharmaceutical companies are increasingly using antimicrobial susceptibility testing to develop innovative therapeutic options, further fueling market growth. The availability of advanced products presents new opportunities for the market. For instance, in January 2023, NanoSynex Ltd. announced plans to commercialize its innovative rapid AST.
Antibiotic Susceptibility Testing Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.1% over the forecast period (2024-2032)
Based on product type segmentation, manual tests was predicted to show maximum market share in the year 2023
Based on application segmentation, drug development was the leading type in 2023
Based on technique segmentation, disk diffusion was the leading type in 2023
On the basis of region, North America was the leading revenue generator in 2023
The Global Antibiotic Susceptibility Testing Market is segmented on the basis of Product Type, Application, End User, Technique, and Region.
The market is divided into three categories based on product type: Manual Test, Automated Instruments and Consumables & Media. Based on product segmentation, the manual tests segment held the largest market share in 2023. The dominance of this segment is attributed to its ease of availability and lower cost compared to automated testing. Additionally, the increasing prevalence of infectious diseases including Neisseria gonorrhoeae, Shigella, Neisseria meningitides, and others is driving the adoption of AST, supporting the growth of the manual tests segment.
The market is divided into five categories based on technique: Automated AST, Etest Method, Dilution, Disk Diffusion and Others. In terms of technique, the disk diffusion segment led the market in 2023. The growth of this segment can be attributed to its advantages, including ease of usage and cost-effectiveness. Furthermore, it allows for the execution of direct susceptibility testing (DST), reducing the turnaround time. However, it is important to note that organizations like the American Society for Microbiology (ASM), the British Society for Antimicrobial Chemotherapy (BSAC), and the European Committee on Antimicrobial Susceptibility Testing (EUCAST) have criticized DST due to the lack of standardization in the inoculum used for such tests.
Antibiotic Susceptibility Testing Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
Companies in the antibiotic susceptibility testing market are employing strategic initiatives to address the increasing demand for accurate and rapid diagnostics in infectious disease management. Ongoing research and development efforts are focused on advancing testing methodologies, incorporating automation, and expanding the range of detectable pathogens. Collaborations with healthcare institutions, laboratories, and pharmaceutical companies are pursued to ensure the development of comprehensive and clinically relevant testing solutions. Additionally, the integration of data analytics and artificial intelligence into testing platforms enhances result interpretation and contributes to personalized treatment approaches. Emphasis on regulatory compliance, quality assurance, and adherence to international guidelines further solidifies the market position of companies providing antibiotic susceptibility testing solutions. As the global healthcare landscape continues to prioritize precision medicine, the antibiotic susceptibility testing market plays a critical role in shaping effective antimicrobial therapies. The industry is moderately fragmented, with a few major players and local companies holding the majority of the market share. Major players are employing various strategies to enhance market growth and increase their market share.
In August 2022, bioMerieux received FDA approval for its SPECIFIC REVEAL Rapid Antimicrobial Susceptibility Test System, which is expected to boost the adoption of rapid AST in treating antimicrobial resistance diseases.
GLOBAL ANTIBIOTIC SUSCEPTIBILITY TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Bio-Rad Laboratories Inc.
Merck & Co., Inc.
Thermo Fisher Scientific Inc.
Danaher Corporation
BD
bioMerieux SA
Creative Diagnostics
Hi-Media Laboratories Pvt. Ltd.
ELITechGroup
F. Hoffmann-La Roche Ltd
Others